HXBM HXBM

Helix Biomedix (PK) Stock Price

12.0001
0.00 (0.0%)
12.0001
Volume 0.00
Bid Price 12.21
Ask Price 50.00
News -
Day High

Low
12.0001

52 Week Range

High
24.80

Day Low
Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
VAT not included
Company Name Stock Ticker Symbol Market Type
Helix Biomedix Inc (PK) HXBM OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 12.0001 07:50:32
Open Price Low Price High Price Close Price Prev Close
12.0001 12.0001
Trades Volume Avg Volume 52 Week Range
0 0.00 - 12.0001 - 24.80
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 12.0001 USD

Period:

Draw Mode:

Helix Biomedix Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.70M 224.71k - $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
13.00 $ - - - -

more financials information »

Helix Biomedix (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical HXBM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months12.000112.000112.000112.002190.000.0%
1 Year24.8024.8012.000122.77276-12.80-51.61%
3 Years47.3047.3012.000130.07289-35.30-74.63%
5 Years47.3047.3012.000135.77150-35.30-74.63%

Helix Biomedix (PK) Description

Helix BioMedix is a preclinical biopharmaceutical company focused on drug development for treatment of rare dermatological diseases, such as xeroderma pigmentosum. Our legacy R&D consists of an extensive proprietary library of patented bioactive peptides based on the body's innate immunity many of which the company has outlicensed to partners to commercialize. Helix BioMedix, Inc., is committed to building long term shareholder value through development of novel drugs for rare dermatological conditions with unmet needs and strategic management of our diverse peptide library.


Your Recent History
USOTC
HXBM
Helix Biom..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.